Interim Report January - September 2026

GOTHENBURG, SE / ACCESS Newswire / October 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2026 (Jul-Sep)Net sales amounted to SEK 252.6 million (189.1), corresponding to a growth of 34 percent in SEK.Organic growth was 32 …